LENZ Therapeutics, Inc. Quarterly Return On Equity in % from Q4 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
LENZ Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2021 to Q3 2024.
  • LENZ Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2024 was -89.9 %, a 158% decline year-over-year.
  • LENZ Therapeutics, Inc. annual Return On Equity for 2023 was 199 %.
  • LENZ Therapeutics, Inc. annual Return On Equity for 2022 was -40.8 %, a 55.4% decline from 2021.
  • LENZ Therapeutics, Inc. annual Return On Equity for 2021 was -26.2 %, a 107% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -89.9 -246 -158% Jul 1, 2024 Sep 30, 2024
Q2 2024 -217 -67 -44.6% Apr 1, 2024 Jun 30, 2024
Q1 2024 3.36K +3.42K Jan 1, 2024 Mar 31, 2024
Q4 2023 199 +240 Oct 1, 2023 Dec 31, 2023
Q3 2023 156 +183 Jul 1, 2023 Sep 30, 2023
Q2 2023 -150 -127 -553% Apr 1, 2023 Jun 30, 2023
Q1 2023 -59.2 -39 -193% Jan 1, 2023 Mar 31, 2023
Q4 2022 -40.8 -14.5 -55.4% Oct 1, 2022 Dec 31, 2022
Q3 2022 -27.3 Jul 1, 2022 Sep 30, 2022
Q2 2022 -23 Apr 1, 2022 Jun 30, 2022
Q1 2022 -20.2 Jan 1, 2022 Mar 31, 2022
Q4 2021 -26.2 Oct 1, 2021 Dec 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.